Ameritas Investment Partners’s OptiNose OPTN Stock Holding History

Ameritas Investment Partners’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-401	Closed	-$8.79K	–	3202
2024 Q1	$8.79K	Hold	401	–	–	﹤0.01%	2847
2023 Q4	$7.77K	Hold	401	–	–	﹤0.01%	2904
2023 Q3	$7.41K	Hold	401	–	–	﹤0.01%	2916
2023 Q2	$7.41K	Buy	+401	New	+$9.48K	﹤0.01%	2983
2021 Q2	–	Sell	-139	Closed	-$8K	–	3181
2021 Q1	$8K	Hold	139	–	–	﹤0.01%	2925
2020 Q4	$9K	Hold	139	–	–	﹤0.01%	2832
2020 Q3	$8K	Hold	139	–	–	﹤0.01%	2816
2020 Q2	$16K	Hold	139	–	–	﹤0.01%	2467
2020 Q1	$9K	Hold	139	–	–	﹤0.01%	2604
2019 Q4	$19K	Buy	139 +53	+62%	+$6.87K	﹤0.01%	2435
2019 Q3	$9K	Hold	86	–	–	﹤0.01%	2788
2019 Q2	$9K	Hold	86	–	–	﹤0.01%	2831
2019 Q1	$13K	Hold	86	–	–	﹤0.01%	2604
2018 Q4	$8K	Hold	86	–	–	﹤0.01%	2744
2018 Q3	$16K	Hold	86	–	–	﹤0.01%	2622
2018 Q2	$36K	Buy	86 +55	+177%	+$18.5K	﹤0.01%	2191
2018 Q1	$9K	Hold	31	–	–	﹤0.01%	2756
2017 Q4	$9K	Buy	+31	New	+$8.72K	﹤0.01%	2782

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameritas Investment Partners's OPTN Position: Q2 2024 in Review

Ameritas Investment Partners sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 401 shares — an estimated $8.79K sold.

Ameritas Investment Partners first reported a position in OPTN in Q4 2017 and held it in 18 quarters. The position peaked at $36K in Q2 2018. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

Ameritas Investment Partners reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
Ameritas Investment Partners sold 401 OptiNose shares in Q2 2024, an estimated $8.79K.
Ameritas Investment Partners first reported a position in OptiNose in Q4 2017 and held it in 18 quarters.
Ameritas Investment Partners's OptiNose position peaked at $36K in Q2 2018.
84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.